{"nct_id":"NCT03012061","title":"Phase IIb Study of Umeclidinium (UMEC) Bromide Versus Placebo in Subjects With Asthma","status":"COMPLETED","status_verified_date":"2020-10","start_date":"2017-01-25","start_date_type":"ACTUAL","primary_completion_date":"2018-05-30","primary_completion_date_type":"ACTUAL","completion_date":"2018-05-30","completion_date_type":"ACTUAL","phases":["PHASE2"],"tickers":["GSK"]}